The relationship between homocysteine and post-stroke depression in patients with spontaneous intracerebral

Chao Zhang1, Guojuan Chen1, Peng Ding1

  • 1Department of Neurology, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Clinical College of Neurology, Neurosurgery, and Neurorehabilitation, Huanhu Hospital, Tianjin Medical University, 6 Jizhao Rd, Tianjin, 300350, China.

BMC Neurology
|May 8, 2026
PubMed

Insights

Post-stroke depression (PSD) is common after intracerebral hemorrhage. This study found PSD more frequent in patients with hyperhomocysteinemia (HHcy), with folic acid improving depression scores.

Area of Science:

  • Neurology
  • Psychiatry
  • Biochemistry

Background:

  • Post-stroke depression (PSD) is a frequent and burdensome complication following stroke.
  • This study investigates the relationship between PSD and homocysteine (HCY) levels in patients with spontaneous intracerebral hemorrhage (SICH).

Purpose of the Study:

  • To determine the association between post-stroke depression (PSD) and homocysteine (HCY) levels in patients with SICH.
  • To evaluate the impact of folic acid and antidepressant medications (ADM) on depression scores in patients with comorbid PSD and hyperhomocysteinemia (HHcy).

Main Methods:

  • Data from 1,852 hemorrhagic stroke (HS) patients were analyzed.
  • Demographic, clinical characteristics, HAM-D17 scores, and HCY levels at 3 months were recorded.
  • Treatment with ADM and folic acid was assessed in patients with PSD and HHcy.

Main Results:

  • PSD was observed in 34.7% and hyperhomocysteinemia (HHcy) in 32.3% of patients; 19.7% had both.
  • A significant link was found between depression and low HCY levels (OR, 1.549).
  • Left-sided stroke, anterior circulation stroke, intraventricular hemorrhage, paralysis, dysarthria, and higher NIHSS scores were associated with PSD. Folic acid plus ADM significantly reduced HAM-D17 scores compared to ADM alone.

Conclusions:

  • PSD is significantly more frequent in patients with HHcy following SICH.
  • Hemorrhage location and disease severity correlate with PSD incidence.
  • Folic acid combined with ADM demonstrated significant improvement in depression scores for patients with comorbid PSD and HHcy.
Abstract

Related Concept Videos

Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...